-transparent.png){kind=logo}
The effects on the coagulative and rheologic pattern of two lipid-lowering drugs, bezafibrate and simvastatin, were studied in 36 hypercholesterolemic subjects. Patients were randomly divided into two groups (18 subjects each) and received bezafibrate R 400 mg/day or simvatatin 10-40 mg/day over a twelve week period. Besides a decrease in plasma fibrinogen and fibrinopeptide A (p less than 0.001 both), bezafibrate induced a reduction of factor VIIc and VIIIc activity (p less than 0.001 both), while antithrombin 3 activity was increased (p less than 0.001) and the hemorheologic pattern was greatly improved (p less than 0.001). Simvastatin caused a slight decrease in factor VIIIc activity and a moderate reduction of beta-thromboglobulin. The efficacy of bezafibrate in reducing the activation of the coagulative cascade and improving the hemorheologic pattern has been confirmed; the peculiar triglycerides- and fibrinogen-lowering effect of the drug, not observed with simvastatin, could be responsible for these modifications.
M Bo, and
F Bonino, and
M Neirotti, and
M Gottero, and
L Pernigotti, and
M Molaschi, and
F Fabris
April 1991,
Plant foods for human nutrition (Dordrecht, Netherlands),
M Bo, and
F Bonino, and
M Neirotti, and
M Gottero, and
L Pernigotti, and
M Molaschi, and
F Fabris
April 2007,
Lipids in health and disease,
M Bo, and
F Bonino, and
M Neirotti, and
M Gottero, and
L Pernigotti, and
M Molaschi, and
F Fabris
December 1975,
Lipids,
M Bo, and
F Bonino, and
M Neirotti, and
M Gottero, and
L Pernigotti, and
M Molaschi, and
F Fabris
November 2002,
Diabetes care,
M Bo, and
F Bonino, and
M Neirotti, and
M Gottero, and
L Pernigotti, and
M Molaschi, and
F Fabris
January 2004,
PharmacoEconomics,
M Bo, and
F Bonino, and
M Neirotti, and
M Gottero, and
L Pernigotti, and
M Molaschi, and
F Fabris
December 2004,
JAMA,
M Bo, and
F Bonino, and
M Neirotti, and
M Gottero, and
L Pernigotti, and
M Molaschi, and
F Fabris
January 2013,
Journal of clinical lipidology,
M Bo, and
F Bonino, and
M Neirotti, and
M Gottero, and
L Pernigotti, and
M Molaschi, and
F Fabris
June 1975,
The Medical letter on drugs and therapeutics,
M Bo, and
F Bonino, and
M Neirotti, and
M Gottero, and
L Pernigotti, and
M Molaschi, and
F Fabris
August 1985,
The Medical letter on drugs and therapeutics,
M Bo, and
F Bonino, and
M Neirotti, and
M Gottero, and
L Pernigotti, and
M Molaschi, and
F Fabris
May 1992,
AACN clinical issues in critical care nursing,
